Powering Inspiration

Enhance your clinical trials knowledge of antibody drug conjugates and IO combination therapies  through access to Beacon – the clinical trials intelligence service.

In the fast-moving field of target-based therapies, Beacon helps scientists and strategists make better drug development decisions faster. Our modular, web-based approach is tailored to provide effortless access to our unique, proprietary data and expert analysis in real time.

With a laser-like focus on antibody drug conjugates and immuno-oncology combination therapies, we are able to provide clear, concise and unambiguous scientific evidence as well as commercial insight.

Beacon has impeccable credentials. It is part of  Hanson Wade  – a global information networking business which runs over 100  conferences a year including the  prestigious annual World ADC Summits in Berlin and San Diego as well as  Immune Checkpoint Inhibitor conferences, Cell and Viral Immunotherapy events and Diagnostics, to name but a few.

“It helps me hone in on the competitors quickly and simply,” Head of Competitive Intelligence, Top 10 Pharma

“If you use Beacon you're not missing anything. It’s a huge time saver, quite frankly” Chief Scientific Officer, leading Biotech

“Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything,” Director of Research, leading antibody research establishment

Founding Partners
aduro Agensys 140x70
curis Eisai 140x70
Genmab 140x70 Immunogen 140x70
Pfizer 140x70 3_regn_standard_logo
Takeda 140x70